JFL Life Sciences Ltd - JFL LIFE Share Price

Summary

JFL Life Sciences Ltd. was incorporated as JFL Life Sciences Private Limited on April 25, 2010 as a Private Limited Company under Companies Act, 1956. Pursuant to a Special Resolution held on February 10, 2022, Company converted from a Private Limited to Public Limited Company and name of the Company was changed to JFL Life Sciences Limited, on March 3, 2022. The Company primarily manufactures and market pharmaceutical products. Its product portfolio consists of Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet and Capsules (general) and Oral Rehydration Solutions (ORS). The Company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care, it has laid a strong R&D foundation and a FDA approved manufacturing facility near Ahmedabad. It also export products to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. For the purpose of identification equipment / machinery / containers are appropriately labelled to identify the stage of process. In case of tablets, the materials are quarantined after granulation, compression, coating and final packing operations for clearance from Q.A. before pursuing the next stage of process. In case of capsule, the materials are quarantined after mixing, filling and final... Read More